Essex Bio-Technology (HKSE:01061) EBIT per Share : HK$0.66 (TTM As of Dec. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Essex Bio-Technology EBIT per Share?

Essex Bio-Technology's EBIT per Share for the six months ended in Dec. 2024 was HK$0.32. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2024 was HK$0.66.

During the past 12 months, the average EBIT per Share Growth Rate of Essex Bio-Technology was 8.70% per year. During the past 3 years, the average EBIT per Share Growth Rate was -3.80% per year. During the past 5 years, the average EBIT per Share Growth Rate was 4.30% per year. During the past 10 years, the average EBIT per Share Growth Rate was 11.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Essex Bio-Technology's EBIT per Share or its related term are showing as below:

HKSE:01061' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -41.5 Med: 29.6 Max: 188.4
Current: -3.8

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Essex Bio-Technology was 188.40% per year. The lowest was -41.50% per year. And the median was 29.60% per year.

HKSE:01061's 3-Year EBIT Growth Rate is ranked worse than
68.12% of 825 companies
in the Drug Manufacturers industry
Industry Median: 8.3 vs HKSE:01061: -3.80

Essex Bio-Technology's EBIT for the six months ended in Dec. 2024 was HK$181 Mil.

Essex Bio-Technology EBIT per Share Historical Data

The historical data trend for Essex Bio-Technology's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Essex Bio-Technology EBIT per Share Chart

Essex Bio-Technology Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EBIT per Share

Get a 7-Day Free Trial

0.42

0.67

0.45

0.60

0.66

Essex Bio-Technology Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
EBIT per Share	Get a 7-Day Free Trial															0.18	0.36	0.24	0.34	0.32

Essex Bio-Technology EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Essex Bio-Technology's EBIT per Share for the fiscal year that ended in Dec. 2024 is calculated as

	EBIT per Share		(A: Dec. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	381.587	/	582.320
=	0.66

Essex Bio-Technology's EBIT per Share for the quarter that ended in Dec. 2024 is calculated as

	EBIT per Share		(Q: Dec. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	180.765	/	571.668
=	0.32

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.66

Essex Bio-Technology (HKSE:01061) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Essex Bio-Technology EBIT per Share Related Terms

Thank you for viewing the detailed overview of Essex Bio-Technology's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Essex Bio-Technology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Essex Bio-Technology Ltd (HKSE:01061) » Definitions » EBIT per Share

Traded in Other Exchanges

N/A

Address

No. 88, Keji 6th Road, Hi-Tech Zone, Guangdong, Zhuhai, CHN

Website

http://www.essexbio.com

Essex Bio-Technology Ltd is principally engaged in investment holding and development, manufacture and sale of biologic drugs in the People's Republic of China. The company is made up of segments of Ophthalmology products and Surgical products. Its products under Ophthalmology include the Beifushu series, Tobramycin Eye Drops, Levofloxacin Eye Drops, Sodium Hyaluronate Eye Drops. The products under Surgical include the Beifuji series, Carisolv dental caries removal gel and mouth wash. The majority of the groups revenue comes from PRC.

Executives

Lauw Hui Kian
Ngiam Mia Je Patrick
Ngiam Mia Kiat Benjamin	2101 Beneficial owner

Essex Bio-Technology Headlines

No Headlines